Clinical trial
The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related…
NCT00002366 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00002366 |
|---|---|
| Title | The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma |
| Official title | A Phase II Safety and Activity Study of Ritonavir in the Treatment of HIV-Associated Cutaneous Kaposi's Sarcoma |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma, Kaposi, HIV Infections |
| Intervention type | Drug |
| Interventions | Ritonavir |
| First posted | Aug 31, 2001 |
| Last update posted | Feb 20, 2009 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: